nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—Phenobarbital—CYP4B1—urinary bladder cancer	0.0469	1	CrCbGaD
Pentobarbital—Injection site reaction—Mitomycin—urinary bladder cancer	0.0323	0.0366	CcSEcCtD
Pentobarbital—Anaemia megaloblastic—Methotrexate—urinary bladder cancer	0.0299	0.0338	CcSEcCtD
Pentobarbital—Hypoxia—Thiotepa—urinary bladder cancer	0.0257	0.0291	CcSEcCtD
Pentobarbital—Hypoxia—Gemcitabine—urinary bladder cancer	0.0217	0.0245	CcSEcCtD
Pentobarbital—Liver injury—Cisplatin—urinary bladder cancer	0.0152	0.0172	CcSEcCtD
Pentobarbital—Respiratory failure—Gemcitabine—urinary bladder cancer	0.014	0.0158	CcSEcCtD
Pentobarbital—Feeling abnormal—Valrubicin—urinary bladder cancer	0.0139	0.0157	CcSEcCtD
Pentobarbital—Apnoea—Etoposide—urinary bladder cancer	0.0139	0.0157	CcSEcCtD
Pentobarbital—Injection site reaction—Gemcitabine—urinary bladder cancer	0.0137	0.0155	CcSEcCtD
Pentobarbital—Body temperature increased—Valrubicin—urinary bladder cancer	0.0133	0.0151	CcSEcCtD
Pentobarbital—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.0128	0.0145	CcSEcCtD
Pentobarbital—Syncope—Mitomycin—urinary bladder cancer	0.0127	0.0144	CcSEcCtD
Pentobarbital—Loss of consciousness—Mitomycin—urinary bladder cancer	0.0125	0.0141	CcSEcCtD
Pentobarbital—Body temperature increased—Carboplatin—urinary bladder cancer	0.0123	0.0139	CcSEcCtD
Pentobarbital—Confusional state—Mitomycin—urinary bladder cancer	0.0117	0.0132	CcSEcCtD
Pentobarbital—Shock—Mitomycin—urinary bladder cancer	0.0114	0.0129	CcSEcCtD
Pentobarbital—Ataxia—Thiotepa—urinary bladder cancer	0.0112	0.0126	CcSEcCtD
Pentobarbital—Dizziness—Valrubicin—urinary bladder cancer	0.0111	0.0126	CcSEcCtD
Pentobarbital—Hypoxia—Methotrexate—urinary bladder cancer	0.0111	0.0125	CcSEcCtD
Pentobarbital—Vomiting—Valrubicin—urinary bladder cancer	0.0107	0.0121	CcSEcCtD
Pentobarbital—Rash—Valrubicin—urinary bladder cancer	0.0106	0.012	CcSEcCtD
Pentobarbital—Dermatitis—Valrubicin—urinary bladder cancer	0.0106	0.012	CcSEcCtD
Pentobarbital—Headache—Valrubicin—urinary bladder cancer	0.0106	0.0119	CcSEcCtD
Pentobarbital—Somnolence—Mitomycin—urinary bladder cancer	0.0103	0.0117	CcSEcCtD
Pentobarbital—Nausea—Valrubicin—urinary bladder cancer	0.01	0.0113	CcSEcCtD
Pentobarbital—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00956	0.0108	CcSEcCtD
Pentobarbital—Ataxia—Fluorouracil—urinary bladder cancer	0.00923	0.0104	CcSEcCtD
Pentobarbital—Body temperature increased—Mitomycin—urinary bladder cancer	0.00917	0.0104	CcSEcCtD
Pentobarbital—Apnoea—Methotrexate—urinary bladder cancer	0.0083	0.00939	CcSEcCtD
Pentobarbital—Hallucination—Thiotepa—urinary bladder cancer	0.00817	0.00924	CcSEcCtD
Pentobarbital—Liver injury—Epirubicin—urinary bladder cancer	0.00783	0.00885	CcSEcCtD
Pentobarbital—Dizziness—Mitomycin—urinary bladder cancer	0.00767	0.00868	CcSEcCtD
Pentobarbital—Vomiting—Mitomycin—urinary bladder cancer	0.00738	0.00834	CcSEcCtD
Pentobarbital—Rash—Mitomycin—urinary bladder cancer	0.00732	0.00827	CcSEcCtD
Pentobarbital—Dermatitis—Mitomycin—urinary bladder cancer	0.00731	0.00827	CcSEcCtD
Pentobarbital—Headache—Mitomycin—urinary bladder cancer	0.00727	0.00822	CcSEcCtD
Pentobarbital—Liver injury—Doxorubicin—urinary bladder cancer	0.00724	0.00819	CcSEcCtD
Pentobarbital—Respiratory failure—Methotrexate—urinary bladder cancer	0.00717	0.0081	CcSEcCtD
Pentobarbital—Tension—Thiotepa—urinary bladder cancer	0.00702	0.00793	CcSEcCtD
Pentobarbital—Nervousness—Thiotepa—urinary bladder cancer	0.00694	0.00785	CcSEcCtD
Pentobarbital—Nausea—Mitomycin—urinary bladder cancer	0.00689	0.00779	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.00679	0.00768	CcSEcCtD
Pentobarbital—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00659	0.00745	CcSEcCtD
Pentobarbital—Agitation—Thiotepa—urinary bladder cancer	0.00657	0.00743	CcSEcCtD
Pentobarbital—Bradycardia—Cisplatin—urinary bladder cancer	0.00656	0.00741	CcSEcCtD
Pentobarbital—Injection site reaction—Epirubicin—urinary bladder cancer	0.00655	0.0074	CcSEcCtD
Pentobarbital—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00609	0.00689	CcSEcCtD
Pentobarbital—Anxiety—Thiotepa—urinary bladder cancer	0.00607	0.00686	CcSEcCtD
Pentobarbital—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00606	0.00685	CcSEcCtD
Pentobarbital—Confusional state—Thiotepa—urinary bladder cancer	0.00588	0.00665	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.00541	0.00612	CcSEcCtD
Pentobarbital—Somnolence—Thiotepa—urinary bladder cancer	0.00519	0.00587	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.00507	0.00573	CcSEcCtD
Pentobarbital—Constipation—Thiotepa—urinary bladder cancer	0.00499	0.00564	CcSEcCtD
Pentobarbital—Confusional state—Fluorouracil—urinary bladder cancer	0.00487	0.0055	CcSEcCtD
Pentobarbital—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00481	0.00544	CcSEcCtD
Pentobarbital—Ataxia—Methotrexate—urinary bladder cancer	0.0048	0.00543	CcSEcCtD
Pentobarbital—Anxiety—Cisplatin—urinary bladder cancer	0.00476	0.00538	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00469	0.0053	CcSEcCtD
Pentobarbital—Body temperature increased—Thiotepa—urinary bladder cancer	0.00461	0.00522	CcSEcCtD
Pentobarbital—Hypotension—Gemcitabine—urinary bladder cancer	0.00459	0.00519	CcSEcCtD
Pentobarbital—Loss of consciousness—Etoposide—urinary bladder cancer	0.00451	0.00511	CcSEcCtD
Pentobarbital—Hypotension—Fluorouracil—urinary bladder cancer	0.00451	0.0051	CcSEcCtD
Pentobarbital—Ataxia—Epirubicin—urinary bladder cancer	0.00449	0.00508	CcSEcCtD
Pentobarbital—Somnolence—Gemcitabine—urinary bladder cancer	0.00436	0.00494	CcSEcCtD
Pentobarbital—Hypersensitivity—Thiotepa—urinary bladder cancer	0.0043	0.00486	CcSEcCtD
Pentobarbital—Somnolence—Fluorouracil—urinary bladder cancer	0.00429	0.00485	CcSEcCtD
Pentobarbital—Hypotension—Cisplatin—urinary bladder cancer	0.00427	0.00484	CcSEcCtD
Pentobarbital—Confusional state—Etoposide—urinary bladder cancer	0.00423	0.00478	CcSEcCtD
Pentobarbital—Constipation—Gemcitabine—urinary bladder cancer	0.0042	0.00475	CcSEcCtD
Pentobarbital—Ataxia—Doxorubicin—urinary bladder cancer	0.00416	0.0047	CcSEcCtD
Pentobarbital—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00404	0.00457	CcSEcCtD
Pentobarbital—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00398	0.0045	CcSEcCtD
Pentobarbital—Hypotension—Etoposide—urinary bladder cancer	0.00392	0.00443	CcSEcCtD
Pentobarbital—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00388	0.00439	CcSEcCtD
Pentobarbital—Dizziness—Thiotepa—urinary bladder cancer	0.00386	0.00436	CcSEcCtD
Pentobarbital—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00381	0.00431	CcSEcCtD
Pentobarbital—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00377	0.00426	CcSEcCtD
Pentobarbital—Somnolence—Etoposide—urinary bladder cancer	0.00373	0.00421	CcSEcCtD
Pentobarbital—Vomiting—Thiotepa—urinary bladder cancer	0.00371	0.0042	CcSEcCtD
Pentobarbital—Rash—Thiotepa—urinary bladder cancer	0.00368	0.00416	CcSEcCtD
Pentobarbital—Dermatitis—Thiotepa—urinary bladder cancer	0.00368	0.00416	CcSEcCtD
Pentobarbital—Headache—Thiotepa—urinary bladder cancer	0.00366	0.00413	CcSEcCtD
Pentobarbital—Body temperature increased—Cisplatin—urinary bladder cancer	0.00362	0.00409	CcSEcCtD
Pentobarbital—Constipation—Etoposide—urinary bladder cancer	0.00358	0.00405	CcSEcCtD
Pentobarbital—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00356	0.00402	CcSEcCtD
Pentobarbital—Nausea—Thiotepa—urinary bladder cancer	0.00347	0.00392	CcSEcCtD
Pentobarbital—Feeling abnormal—Etoposide—urinary bladder cancer	0.00345	0.00391	CcSEcCtD
Pentobarbital—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00337	0.00381	CcSEcCtD
Pentobarbital—Bradycardia—Epirubicin—urinary bladder cancer	0.00337	0.00381	CcSEcCtD
Pentobarbital—Body temperature increased—Etoposide—urinary bladder cancer	0.00331	0.00375	CcSEcCtD
Pentobarbital—Dizziness—Fluorouracil—urinary bladder cancer	0.00319	0.00361	CcSEcCtD
Pentobarbital—Vomiting—Gemcitabine—urinary bladder cancer	0.00312	0.00353	CcSEcCtD
Pentobarbital—Bradycardia—Doxorubicin—urinary bladder cancer	0.00311	0.00352	CcSEcCtD
Pentobarbital—Rash—Gemcitabine—urinary bladder cancer	0.00309	0.0035	CcSEcCtD
Pentobarbital—Dermatitis—Gemcitabine—urinary bladder cancer	0.00309	0.0035	CcSEcCtD
Pentobarbital—Hypersensitivity—Etoposide—urinary bladder cancer	0.00309	0.00349	CcSEcCtD
Pentobarbital—Headache—Gemcitabine—urinary bladder cancer	0.00307	0.00348	CcSEcCtD
Pentobarbital—Vomiting—Fluorouracil—urinary bladder cancer	0.00307	0.00347	CcSEcCtD
Pentobarbital—Rash—Fluorouracil—urinary bladder cancer	0.00304	0.00344	CcSEcCtD
Pentobarbital—Dermatitis—Fluorouracil—urinary bladder cancer	0.00304	0.00344	CcSEcCtD
Pentobarbital—Headache—Fluorouracil—urinary bladder cancer	0.00302	0.00342	CcSEcCtD
Pentobarbital—Nausea—Gemcitabine—urinary bladder cancer	0.00292	0.0033	CcSEcCtD
Pentobarbital—Vomiting—Cisplatin—urinary bladder cancer	0.00291	0.00329	CcSEcCtD
Pentobarbital—Rash—Cisplatin—urinary bladder cancer	0.00288	0.00326	CcSEcCtD
Pentobarbital—Dermatitis—Cisplatin—urinary bladder cancer	0.00288	0.00326	CcSEcCtD
Pentobarbital—Nausea—Fluorouracil—urinary bladder cancer	0.00287	0.00324	CcSEcCtD
Pentobarbital—Tension—Epirubicin—urinary bladder cancer	0.00282	0.00319	CcSEcCtD
Pentobarbital—Nervousness—Epirubicin—urinary bladder cancer	0.0028	0.00316	CcSEcCtD
Pentobarbital—Dizziness—Etoposide—urinary bladder cancer	0.00277	0.00313	CcSEcCtD
Pentobarbital—Nausea—Cisplatin—urinary bladder cancer	0.00272	0.00307	CcSEcCtD
Pentobarbital—Vomiting—Etoposide—urinary bladder cancer	0.00266	0.00301	CcSEcCtD
Pentobarbital—Agitation—Epirubicin—urinary bladder cancer	0.00265	0.00299	CcSEcCtD
Pentobarbital—Rash—Etoposide—urinary bladder cancer	0.00264	0.00299	CcSEcCtD
Pentobarbital—Dermatitis—Etoposide—urinary bladder cancer	0.00264	0.00299	CcSEcCtD
Pentobarbital—Headache—Etoposide—urinary bladder cancer	0.00263	0.00297	CcSEcCtD
Pentobarbital—Tension—Doxorubicin—urinary bladder cancer	0.00261	0.00296	CcSEcCtD
Pentobarbital—Nervousness—Doxorubicin—urinary bladder cancer	0.00259	0.00293	CcSEcCtD
Pentobarbital—Syncope—Epirubicin—urinary bladder cancer	0.00258	0.00292	CcSEcCtD
Pentobarbital—Confusional state—Methotrexate—urinary bladder cancer	0.00253	0.00286	CcSEcCtD
Pentobarbital—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00253	0.00286	CcSEcCtD
Pentobarbital—Nausea—Etoposide—urinary bladder cancer	0.00249	0.00282	CcSEcCtD
Pentobarbital—Agitation—Doxorubicin—urinary bladder cancer	0.00245	0.00277	CcSEcCtD
Pentobarbital—Anxiety—Epirubicin—urinary bladder cancer	0.00244	0.00276	CcSEcCtD
Pentobarbital—Syncope—Doxorubicin—urinary bladder cancer	0.00239	0.0027	CcSEcCtD
Pentobarbital—Confusional state—Epirubicin—urinary bladder cancer	0.00237	0.00268	CcSEcCtD
Pentobarbital—Hypotension—Methotrexate—urinary bladder cancer	0.00235	0.00265	CcSEcCtD
Pentobarbital—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00234	0.00265	CcSEcCtD
Pentobarbital—Shock—Epirubicin—urinary bladder cancer	0.00231	0.00261	CcSEcCtD
Pentobarbital—Anxiety—Doxorubicin—urinary bladder cancer	0.00226	0.00256	CcSEcCtD
Pentobarbital—Somnolence—Methotrexate—urinary bladder cancer	0.00223	0.00252	CcSEcCtD
Pentobarbital—Hypotension—Epirubicin—urinary bladder cancer	0.0022	0.00248	CcSEcCtD
Pentobarbital—Confusional state—Doxorubicin—urinary bladder cancer	0.00219	0.00248	CcSEcCtD
Pentobarbital—Shock—Doxorubicin—urinary bladder cancer	0.00214	0.00242	CcSEcCtD
Pentobarbital—Somnolence—Epirubicin—urinary bladder cancer	0.00209	0.00236	CcSEcCtD
Pentobarbital—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00207	0.00234	CcSEcCtD
Pentobarbital—Hypotension—Doxorubicin—urinary bladder cancer	0.00203	0.0023	CcSEcCtD
Pentobarbital—Constipation—Epirubicin—urinary bladder cancer	0.00201	0.00227	CcSEcCtD
Pentobarbital—Body temperature increased—Methotrexate—urinary bladder cancer	0.00198	0.00224	CcSEcCtD
Pentobarbital—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00194	0.00219	CcSEcCtD
Pentobarbital—Somnolence—Doxorubicin—urinary bladder cancer	0.00193	0.00219	CcSEcCtD
Pentobarbital—Constipation—Doxorubicin—urinary bladder cancer	0.00186	0.0021	CcSEcCtD
Pentobarbital—Body temperature increased—Epirubicin—urinary bladder cancer	0.00186	0.0021	CcSEcCtD
Pentobarbital—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00185	0.00209	CcSEcCtD
Pentobarbital—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00179	0.00203	CcSEcCtD
Pentobarbital—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00173	0.00196	CcSEcCtD
Pentobarbital—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00172	0.00194	CcSEcCtD
Pentobarbital—Dizziness—Methotrexate—urinary bladder cancer	0.00166	0.00188	CcSEcCtD
Pentobarbital—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.0016	0.00181	CcSEcCtD
Pentobarbital—Vomiting—Methotrexate—urinary bladder cancer	0.0016	0.00181	CcSEcCtD
Pentobarbital—Rash—Methotrexate—urinary bladder cancer	0.00158	0.00179	CcSEcCtD
Pentobarbital—Dermatitis—Methotrexate—urinary bladder cancer	0.00158	0.00179	CcSEcCtD
Pentobarbital—Headache—Methotrexate—urinary bladder cancer	0.00157	0.00178	CcSEcCtD
Pentobarbital—Dizziness—Epirubicin—urinary bladder cancer	0.00155	0.00176	CcSEcCtD
Pentobarbital—Vomiting—Epirubicin—urinary bladder cancer	0.00149	0.00169	CcSEcCtD
Pentobarbital—Nausea—Methotrexate—urinary bladder cancer	0.00149	0.00169	CcSEcCtD
Pentobarbital—Rash—Epirubicin—urinary bladder cancer	0.00148	0.00168	CcSEcCtD
Pentobarbital—Dermatitis—Epirubicin—urinary bladder cancer	0.00148	0.00167	CcSEcCtD
Pentobarbital—Headache—Epirubicin—urinary bladder cancer	0.00147	0.00166	CcSEcCtD
Pentobarbital—Dizziness—Doxorubicin—urinary bladder cancer	0.00144	0.00163	CcSEcCtD
Pentobarbital—Nausea—Epirubicin—urinary bladder cancer	0.0014	0.00158	CcSEcCtD
Pentobarbital—Vomiting—Doxorubicin—urinary bladder cancer	0.00138	0.00156	CcSEcCtD
Pentobarbital—Rash—Doxorubicin—urinary bladder cancer	0.00137	0.00155	CcSEcCtD
Pentobarbital—Dermatitis—Doxorubicin—urinary bladder cancer	0.00137	0.00155	CcSEcCtD
Pentobarbital—Headache—Doxorubicin—urinary bladder cancer	0.00136	0.00154	CcSEcCtD
Pentobarbital—Nausea—Doxorubicin—urinary bladder cancer	0.00129	0.00146	CcSEcCtD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000428	0.00621	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000419	0.00607	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000413	0.00599	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTZ1—urinary bladder cancer	0.000384	0.00557	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000379	0.00549	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTO2—urinary bladder cancer	0.000364	0.00528	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—NAT1—urinary bladder cancer	0.000364	0.00528	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00036	0.00523	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000359	0.0052	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000358	0.00519	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000354	0.00513	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000339	0.00492	CbGpPWpGaD
Pentobarbital—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000338	0.0049	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—UGT2B7—urinary bladder cancer	0.000333	0.00483	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000328	0.00476	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—NAT2—urinary bladder cancer	0.000327	0.00474	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000323	0.00469	CbGpPWpGaD
Pentobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—urinary bladder cancer	0.000323	0.00468	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000314	0.00456	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000309	0.00447	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000303	0.0044	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000301	0.00437	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP4B1—urinary bladder cancer	0.0003	0.00435	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000296	0.00429	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000296	0.00429	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000283	0.0041	CbGpPWpGaD
Pentobarbital—GABRA6—Orphan transporters—CREBBP—urinary bladder cancer	0.000273	0.00396	CbGpPWpGaD
Pentobarbital—GABRA4—Orphan transporters—CREBBP—urinary bladder cancer	0.00027	0.00391	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000268	0.00389	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—HPGDS—urinary bladder cancer	0.000261	0.00379	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000259	0.00376	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000259	0.00375	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000256	0.00371	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTT1—urinary bladder cancer	0.000254	0.00368	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000253	0.00367	CbGpPWpGaD
Pentobarbital—GABRB2—Orphan transporters—CREBBP—urinary bladder cancer	0.000247	0.00358	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—NQO1—urinary bladder cancer	0.00024	0.00348	CbGpPWpGaD
Pentobarbital—GABRA5—Orphan transporters—CREBBP—urinary bladder cancer	0.00024	0.00348	CbGpPWpGaD
Pentobarbital—GABRA3—Orphan transporters—CREBBP—urinary bladder cancer	0.000235	0.00341	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000234	0.00339	CbGpPWpGaD
Pentobarbital—GABRA2—Orphan transporters—CREBBP—urinary bladder cancer	0.000231	0.00336	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000231	0.00335	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00023	0.00334	CbGpPWpGaD
Pentobarbital—GABRB3—Orphan transporters—CREBBP—urinary bladder cancer	0.00023	0.00333	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000228	0.0033	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000227	0.00329	CbGpPWpGaD
Pentobarbital—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	0.000226	0.00327	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000225	0.00326	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000223	0.00324	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000219	0.00318	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000219	0.00317	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000219	0.00317	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000218	0.00316	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000216	0.00313	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000214	0.0031	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000211	0.00306	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000208	0.00302	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000203	0.00294	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.0002	0.00291	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.0002	0.0029	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000199	0.00289	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000197	0.00286	CbGpPWpGaD
Pentobarbital—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000197	0.00286	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000197	0.00285	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000193	0.00279	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000191	0.00276	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000187	0.00271	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000185	0.00269	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.000184	0.00267	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000183	0.00265	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000182	0.00264	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00018	0.00261	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000179	0.00259	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000178	0.00258	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000178	0.00257	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000176	0.00255	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000174	0.00253	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—SRC—urinary bladder cancer	0.000168	0.00243	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.000162	0.00234	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000159	0.00231	CbGpPWpGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000158	0.00229	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000157	0.00228	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000156	0.00227	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000155	0.00225	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000155	0.00224	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000152	0.00221	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000149	0.00216	CbGpPWpGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000144	0.00208	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000143	0.00207	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000143	0.00207	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000141	0.00204	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000129	0.00187	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000127	0.00185	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000125	0.00181	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000123	0.00178	CbGpPWpGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000121	0.00175	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000121	0.00175	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00012	0.00174	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00012	0.00174	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000119	0.00172	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000118	0.00171	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000118	0.00171	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000118	0.00171	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	0.000117	0.0017	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000117	0.0017	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000115	0.00167	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000113	0.00164	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000108	0.00157	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000108	0.00156	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000107	0.00155	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000106	0.00153	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000103	0.00149	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	0.000102	0.00148	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NAT1—urinary bladder cancer	0.000102	0.00148	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.0001	0.00146	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	9.92e-05	0.00144	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	9.85e-05	0.00143	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.72e-05	0.00141	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.71e-05	0.00141	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.59e-05	0.00139	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	9.34e-05	0.00135	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.3e-05	0.00135	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—HRAS—urinary bladder cancer	9.1e-05	0.00132	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.08e-05	0.00132	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	9.07e-05	0.00132	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.81e-05	0.00128	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.81e-05	0.00128	CbGpPWpGaD
Pentobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.65e-05	0.00125	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.5e-05	0.00123	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.45e-05	0.00123	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	8.41e-05	0.00122	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.3e-05	0.0012	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—HRAS—urinary bladder cancer	8.28e-05	0.0012	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	8.26e-05	0.0012	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	7.94e-05	0.00115	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.89e-05	0.00114	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	7.74e-05	0.00112	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.55e-05	0.00109	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.46e-05	0.00108	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.25e-05	0.00105	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—HRAS—urinary bladder cancer	6.96e-05	0.00101	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.82e-05	0.000989	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—HRAS—urinary bladder cancer	6.75e-05	0.000978	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.67e-05	0.000968	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.62e-05	0.000961	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.59e-05	0.000955	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.57e-05	0.000952	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.51e-05	0.000943	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.45e-05	0.000935	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.39e-05	0.000927	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.36e-05	0.000922	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.35e-05	0.000921	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.24e-05	0.000904	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.22e-05	0.000903	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.22e-05	0.000903	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMP—urinary bladder cancer	6.19e-05	0.000897	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.12e-05	0.000888	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.03e-05	0.000874	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.92e-05	0.000859	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.86e-05	0.000849	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.84e-05	0.000847	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—HRAS—urinary bladder cancer	5.79e-05	0.000839	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.75e-05	0.000834	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—HRAS—urinary bladder cancer	5.71e-05	0.000828	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.69e-05	0.000825	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.65e-05	0.000819	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.61e-05	0.000814	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NAT2—urinary bladder cancer	5.59e-05	0.000811	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.51e-05	0.000799	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.45e-05	0.00079	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—HRAS—urinary bladder cancer	5.22e-05	0.000758	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.13e-05	0.000743	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—HRAS—urinary bladder cancer	5.08e-05	0.000736	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—HRAS—urinary bladder cancer	4.98e-05	0.000723	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—HRAS—urinary bladder cancer	4.9e-05	0.00071	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—HRAS—urinary bladder cancer	4.87e-05	0.000706	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	4.84e-05	0.000702	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—RRM2—urinary bladder cancer	4.83e-05	0.0007	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.82e-05	0.000699	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—HRAS—urinary bladder cancer	4.78e-05	0.000693	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.72e-05	0.000684	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ENO2—urinary bladder cancer	4.47e-05	0.000648	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	4.47e-05	0.000648	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	4.34e-05	0.000629	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—HRAS—urinary bladder cancer	4.18e-05	0.000606	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.95e-05	0.000573	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.78e-05	0.000548	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.77e-05	0.000547	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.74e-05	0.000543	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.74e-05	0.000543	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.62e-05	0.000525	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NQO1—urinary bladder cancer	3.6e-05	0.000523	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.42e-05	0.000496	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.41e-05	0.000495	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.08e-05	0.000447	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	3.01e-05	0.000436	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—RRM2—urinary bladder cancer	2.94e-05	0.000427	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.91e-05	0.000422	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.84e-05	0.000411	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.79e-05	0.000405	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.76e-05	0.000401	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.76e-05	0.000401	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.73e-05	0.000395	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.73e-05	0.000395	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.71e-05	0.000393	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.65e-05	0.000384	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.64e-05	0.000383	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.6e-05	0.000378	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.6e-05	0.000377	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	2.44e-05	0.000354	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.27e-05	0.000329	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.2e-05	0.000319	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.13e-05	0.000309	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.05e-05	0.000297	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.98e-05	0.000287	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.9e-05	0.000276	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.86e-05	0.00027	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.83e-05	0.000266	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.77e-05	0.000257	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.77e-05	0.000257	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.7e-05	0.000247	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.68e-05	0.000244	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.68e-05	0.000244	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.64e-05	0.000238	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.64e-05	0.000238	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.61e-05	0.000234	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.59e-05	0.000231	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.58e-05	0.00023	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.56e-05	0.000226	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	0.000216	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.36e-05	0.000197	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.32e-05	0.000192	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.3e-05	0.000188	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.21e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	0.000168	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.1e-05	0.00016	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.02e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.01e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.01e-05	0.000147	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.7e-06	0.000141	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.52e-06	0.000138	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.5e-06	0.000138	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.95e-06	0.00013	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTEN—urinary bladder cancer	8.28e-06	0.00012	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—EP300—urinary bladder cancer	7.9e-06	0.000115	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.26e-06	0.000105	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.97e-06	0.000101	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.71e-06	8.28e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.98e-06	7.22e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.75e-06	6.89e-05	CbGpPWpGaD
